U.S. Physical Therapy, Inc.
USPH
$73.85
-$0.09-0.12%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 161.95M | 162.19M | 150.70M | 148.21M | 137.43M |
| Total Other Revenue | 33.11M | 33.16M | 31.24M | 30.39M | 28.89M |
| Total Revenue | 195.06M | 195.35M | 181.94M | 178.60M | 166.31M |
| Cost of Revenue | 152.73M | 147.92M | 145.09M | 127.97M | 129.59M |
| Gross Profit | 42.33M | 47.43M | 36.85M | 50.63M | 36.72M |
| SG&A Expenses | 17.41M | 17.48M | 16.25M | 15.57M | 14.39M |
| Depreciation & Amortization | 5.50M | 5.74M | 5.54M | 17.85M | 4.16M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 175.64M | 171.13M | 166.88M | 161.40M | 148.13M |
| Operating Income | 19.42M | 24.22M | 15.06M | 17.20M | 18.18M |
| Income Before Tax | 22.88M | 22.65M | 17.33M | 18.32M | 12.34M |
| Income Tax Expenses | 5.23M | 4.93M | 3.86M | 5.83M | 2.56M |
| Earnings from Continuing Operations | 17.64M | 17.72M | 13.47M | 12.49M | 9.78M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -4.50M | -5.33M | -3.57M | -3.25M | -3.15M |
| Net Income | 13.14M | 12.39M | 9.90M | 9.24M | 6.63M |
| EBIT | 19.42M | 24.22M | 15.06M | 17.20M | 18.18M |
| EBITDA | 25.25M | 30.27M | 20.93M | 22.89M | 22.57M |
| EPS Basic | 0.48 | 0.58 | 0.80 | 0.52 | 0.39 |
| Normalized Basic EPS | 0.40 | 0.55 | 0.30 | 0.44 | 0.52 |
| EPS Diluted | 0.48 | 0.58 | 0.80 | 0.52 | 0.39 |
| Normalized Diluted EPS | 0.40 | 0.55 | 0.30 | 0.44 | 0.52 |
| Average Basic Shares Outstanding | 15.20M | 15.20M | 15.13M | 15.09M | 15.08M |
| Average Diluted Shares Outstanding | 15.20M | 15.20M | 15.13M | 15.09M | 15.08M |
| Dividend Per Share | 0.45 | 0.45 | 0.45 | 0.44 | 0.44 |
| Payout Ratio | 52.08% | 110.37% | -- | 71.85% | 100.09% |